相关实验视频
Updated: May 16, 2025

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
29.7K
韦塞拉混MW051433通过胆汁胆固醇分泌减轻高胆固醇血症:体外证据
Saman Javed1,2, Zakia Latif3, Ghulam Ayesha Javed1
1Institute of Zoology, University of the Punjab, Lahore, 54590, Pakistan.
Current microbiology
|April 1, 2025
概括
这项研究表明,益生菌Weissella confusa及其与曼尼托尔的协生菌通过增加便胆固醇和胆酸分泌,有效地降低小鼠的胆固醇. 仅仅益生菌本身就显示出明显的降胆固醇效应,与同生菌相比较.
科学领域:
- 微生物学和肠道健康
- 代谢障碍和营养问题
- 药理学和治疗学 药理学和治疗学
背景情况:
- 高胆固醇血症是心血管疾病的重要危险因素.
- 饮食干预措施,包括益生菌和益生菌,正在探索胆固醇管理.
- 通过某些益生菌降低胆固醇的具体机制仍在研究中.
研究的目的:
- 为了评估曼尼托 (益生菌) 的降胆固醇潜力,Weissella confusa MW051433 (益生菌) 和它们的协生菌.
- 为了阐明底层机制,专注于胆汁胆固醇分泌.
- 在高胆固醇血的小鼠模型中评估对脂质谱,肝功能和血液学参数的影响.
主要方法:
- 一项为期60天的随机对照研究,使用高脂肪饮食诱导的高胆固醇血症小鼠模型.
- 五组:负对照,阳性对照和三个治疗组 (前生物,益生菌,共生菌).
- 分析包括血清脂质概况,肝胆固醇,肝酶,血液学参数,便胆固醇和胆酸含量.
主要成果:
- 高脂肪饮食显著诱导高胆固醇血症,肝脏胆固醇升高,并改变了血液学参数.
- 韦塞拉混MW051433和同生菌显著改善了脂质谱和肝功能.
- 这两种治疗都显著增加了便中的胆固醇和胆酸分泌,表明胆道胆固醇分泌增加.
结论:
- 韦塞拉混MW051433在体内显示出显著的低胆固醇血清有效性.
- 益生菌促进胆固醇降低,主要是通过增加胆道胆固醇分泌的机制.
- 仅仅益生菌提供了与协生菌相似的结果,突出了其在管理高胆固醇血症方面的治疗潜力.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
475
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
475
Hepatic Drug Excretion: Influencing Factors
64
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
64
Cholesterol: Significance and Regulation
462
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
462
Chronic Bowel Disorders: Introduction
345
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
345
Lipids: Dietary Sources and Requirements
595
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
595
Hepatic Drug Excretion: Enterohepatic Cycling
863
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
863

